F030 Autoimmune Blistering Diseases: What's New?
DESCRIPTION
This session will focus on new advances in AIBD regarding causation of pemphigus, pemphigoid and EBA, along with evidence based treatment and new therapies in the pipeline for pemphigus and pemphigoid.
LEARNING OBJECTIVES
Identify why people get pemphigus and pemphigoid, shorten the time to diagnose a blistering disease, recognize if certain drugs may have triggered the disease to cease them and select the best treatment for the patient with pemphigus and pemphigoid.
Discuss the evidence behind current treatments for pemphigus, bullous pemphigoid and EBA.
Describe new therapies in the pipeline for pemphigoid and pemphigus.
SCHEDULE
3:30 PM
Introduction to all speakers and topics
Dedee F. Murrell, MD, FAAD
3:35 PM
Who develops pemphigus and why?
Eli Sprecher, MD, PhD, IFAAD
3:55 PM
New treatments in the pipeline for pemphigus
Dedee F. Murrell, MD, FAAD
4:15 PM
Rationale for the treatment of bullous pemphigoid
Pascal Joly, MD, PhD, IFAAD
4:35 PM
New treatments in the pipeline for bullous pemphigoid
Aikaterini Patsatsi, MD, PhD, IFAAD
4:55 PM
Epidermolysis bullosa acquisita- what's new
Frederic Caux, PhD
5:15 PM
Q and A
DIRECTOR
Dedee F. Murrell, MD, FAAD
SPEAKERS
Frederic Caux, PhD
Pascal Joly, MD, PhD, IFAAD
Aikaterini Patsatsi, MD, PhD, IFAAD
Eli Sprecher, MD, PhD, IFAAD
HANDOUTS
DISCLOSURES
Frederic Caux, PhD
arGEN-X – Investigator(Fees); Boehringer Ingelheim – Advisory Board(Honoraria); Eli Lilly – Speaker(Honoraria); Galderma – Advisory Board(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Speaker(Honoraria); Regeneron – Investigator(Fees); Sanofi – Advisory Board(Honoraria), Speaker(Honoraria);
Pascal Joly, MD, PhD, IFAAD
AbbVie – Consultant (1099 relationship)(Fees); arGEN-X – Consultant(Honoraria); AstraZeneca – Consultant(Honoraria); BMS – Advisory Board(Honoraria); Glycoera – Consultant (1099 relationship)(Honoraria); janssen – Advisory Board(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Novartis Pharmaceuticals Corp. – Consultant(Honoraria); sanofi-aventis – Consultant(Honoraria); TOPAZ Pharmaceuticals, Inc. – Consultant(Honoraria); UCB – Advisory Board(Honoraria);
Dedee F. Murrell, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Actavis – Speaker/Faculty Education(Honoraria); Almirall – Consultant(Honoraria); Alumis – Investigator(Fees); Amgen – Investigator(Fees); Amicus Therapeutics – Advisory Board(Honoraria); Amryt Pharma – Investigator(Fees); Anacor Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Apogee Therapeutics – Investigator(Fees); Arena Pharmaceuticals – Investigator(Grants/Research Funding); arGEN-X – Investigator(Fees); Ascent Pharmaceuticals – Speaker(Honoraria); Attovia Therapeutics – Investigator(Fees); Bambusa Therapeutics Inc – Advisory Board(Fees); BMS – Investigator(Fees); Castle Creek Pharmaceuticals – Consultant(Fees); Chiesi Farmaceutici – Advisory Board(Fees); CSL – Speaker(Honoraria); Delfin Technology – Investigator(Equipment); Eli Lilly and Company – Advisory Board(Honoraria); Evelo Biosciences, Inc. – Investigator(Fees); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding), Investigator(Other Financial Benefit); Incyte – Investigator(Fees); Johnson & Johnson – Investigator(Grants/Research Funding); Krystal Biotech, Inc – Other(No Compensation Received); L'Oreal – Speaker(Fees); Leo Pharma Inc – Speaker/Faculty Education(Honoraria); Medimmune – Investigator(Fees), Investigator(Grants/Research Funding); Nektar Therapeutics – Investigator(Fees); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Ono – Advisory Board(Fees); Pfizer Inc. – Investigator(Grants/Research Funding); Pierre Fabre Dermo-Cosmétique US – Speaker(Honoraria); Principia Biopharma Inc – Consultant(Honoraria); RAPT Therapeutics – Advisory Board(Fees); Regeneron Pharmaceuticals Inc – Advisory Board(Fees); RHEACELL – Data Safety Monitoring Board(Fees); Roche Laboratories – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Sanofi – Advisory Board(Fees), Investigator(Fees), Investigator(Grants/Research Funding); Schering-Plough Corporation – Investigator(Grants/Research Funding); Shire – Advisory Board(Honoraria), Investigator(Grants/Research Funding); TWi Biotechnology, Inc. – Advisory Board(Fees), Investigator(Fees); UCB – Investigator(Fees); UpToDate – Other(Fees);
Aikaterini Patsatsi, MD, PhD, IFAAD
AbbVie – Speaker(Honoraria); Argenx – Advisory Board(Honoraria); Innovaderm Research Inc. – Advisory Board(Honoraria); Johnson and Johnson – Speaker(Honoraria); Leo Pharma Inc – Speaker(Honoraria); Novartis Hellas – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Pharmaserv Lilly – Speaker(Honoraria); Sanofi – Speaker(Honoraria); UCB – Speaker(Honoraria);
Eli Sprecher, MD, PhD, IFAAD
Amryt Pharma – Consultant (1099 relationship)(Fees); Bayer – Consultant (1099 relationship)(Fees); BiomX Ltd. – Consultant (1099 relationship)(Fees); BiondVax Pharmaceuticals – Consultant (1099 relationship)(Fees); Galmed Pharmaceuticals – Consultant (1099 relationship)(Fees); I-DERM, NGT HealthCare2 – Consultant (1099 relationship)(Fees); Kamari Pharma – Consultant (1099 relationship)(Fees); Krystal Biotech, Inc – Consultant (1099 relationship)(Fees); Laser team – Consultant (1099 relationship)(Fees); Medison Pharma – Consultant (1099 relationship)(Fees); Pincell – Consultant (1099 relationship)(No Compensation Received); Sol-Gel Technologies – Consultant (1099 relationship)(Equipment);